New procedure targets nerves to treat stubborn heart failure

NCT ID NCT07331220

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a procedure called pulmonary artery denervation (PADN) for people with heart failure whose heart pumps normally but is stiff. The procedure uses a catheter to burn nerves in the lung artery, which may help the heart work better. About 310 participants will either get PADN plus standard medications or a sham procedure plus medications. The goal is to see if PADN reduces deaths, hospitalizations, and need for advanced treatments over 12 to 24 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Pulmonary artery denervation (a catheter-based procedure using radiofrequency energy to ablate nerves in the pulmonary artery)
What this could lead to
If successful, this procedure could become a new treatment option for heart failure patients with preserved ejection fraction, reducing hospitalizations and improving survival.
What could go wrong
This is an early-stage trial with a sham control, so results may not show benefit. The procedure involves risks like bleeding, infection, or damage to blood vessels.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE WITH PRESERVED EJECTION FRACTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Nanjing First Hospital, Nanjing Medical University

    Nanjing, Jiangsu, 210006, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.